Controversial New Alzheimer’s Drugs Offer Hope—But at a High Cost

Liz Seegert

Nature, 2025, vol. 645, issue 8081, S10-S12

Abstract: New Alzheimer’s drugs known as anti-amyloid therapies may slow disease progression—but they also carry serious risks, including brain bleeds and strokelike symptoms.

Keywords: Alzheimer's disease; Medical research; Therapeutics (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-025-02927-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:645:y:2025:i:8081:d:10.1038_d41586-025-02927-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-025-02927-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().